46
Participants
Start Date
September 7, 2021
Primary Completion Date
July 31, 2023
Study Completion Date
July 31, 2023
PointCheck
PointCheckTM is intended for use to aid in the assessment of severe neutropenia in the home or clinic setting in subjects receiving myelosuppressive chemotherapy with intermediate to high febrile neutropenia risk. The device non-invasively captures real-time videos of blood flow in the nailfold microcirculation and utilizes visible light, a microscope and a computer vision software to provide a qualitative result. The device is limited to use as a preliminary assessment tool in conjunction with standard of care, including temperature monitoring and clinical assessment. It is not to be used as a stand-alone determinant of severe neutropenia or for any other diagnostic purpose
MD Anderson Cancer Center, Houston
M.D. Anderson Cancer Center
OTHER
Center for Advancing Point of Care Technologies
OTHER
Leuko Labs, Inc.
INDUSTRY